1. Home
  2. RDY vs NVT Comparison

RDY vs NVT Comparison

Compare RDY & NVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RDY
  • NVT
  • Stock Information
  • Founded
  • RDY 1984
  • NVT 1903
  • Country
  • RDY India
  • NVT United Kingdom
  • Employees
  • RDY N/A
  • NVT N/A
  • Industry
  • RDY Biotechnology: Pharmaceutical Preparations
  • NVT Industrial Machinery/Components
  • Sector
  • RDY Health Care
  • NVT Industrials
  • Exchange
  • RDY Nasdaq
  • NVT Nasdaq
  • Market Cap
  • RDY 11.9B
  • NVT 12.0B
  • IPO Year
  • RDY N/A
  • NVT N/A
  • Fundamental
  • Price
  • RDY $15.38
  • NVT $69.59
  • Analyst Decision
  • RDY Buy
  • NVT Strong Buy
  • Analyst Count
  • RDY 1
  • NVT 6
  • Target Price
  • RDY $17.00
  • NVT $85.50
  • AVG Volume (30 Days)
  • RDY 1.6M
  • NVT 1.4M
  • Earning Date
  • RDY 01-28-2025
  • NVT 02-04-2025
  • Dividend Yield
  • RDY 3.74%
  • NVT 1.09%
  • EPS Growth
  • RDY 4.63
  • NVT 21.96
  • EPS
  • RDY 0.76
  • NVT 3.42
  • Revenue
  • RDY $3,579,112,656.00
  • NVT $3,539,100,000.00
  • Revenue This Year
  • RDY $13.39
  • NVT N/A
  • Revenue Next Year
  • RDY $8.35
  • NVT $5.18
  • P/E Ratio
  • RDY $20.68
  • NVT $20.29
  • Revenue Growth
  • RDY 12.37
  • NVT 30.11
  • 52 Week Low
  • RDY $13.41
  • NVT $55.19
  • 52 Week High
  • RDY $16.89
  • NVT $86.57
  • Technical
  • Relative Strength Index (RSI)
  • RDY 66.14
  • NVT 34.64
  • Support Level
  • RDY $14.45
  • NVT $68.96
  • Resistance Level
  • RDY $14.85
  • NVT $76.48
  • Average True Range (ATR)
  • RDY 0.19
  • NVT 2.24
  • MACD
  • RDY 0.13
  • NVT -0.97
  • Stochastic Oscillator
  • RDY 88.17
  • NVT 9.01

About RDY Dr. Reddy's Laboratories Ltd

Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.

About NVT nVent Electric plc

nVent is a leading global provider of electrical connection and protection solutions that touches a broad range of end markets including infrastructure, industrial, commercial, and residential. NVent designs, manufacturers, markets, installs, and services a portfolio of electrical enclosures and electrical fastening solutions. nVent currently has three reportable segments: Enclosures, Electrical & Fastening Solutions, and Thermal Management. Thermal Management is expected to be sold by early 2025. North America accounts for the majority of sales.

Share on Social Networks: